Abelado, Eric V.
HRN: 22-29-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2023
CEFTRIAXONE 1G (VIAL)
02/01/2023
02/07/2023
IV
2gm
OD
Cholelithiasis Cholecystitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes